S-1 Filing

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC CIK: 1730430

Filing Information

Form Type	S-1
Accession Number	`0001047469-19-000263`
Period End Date	20180930
Filing Date	20190128
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	knsa-20190114.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 60 Cash Flow Statement 69 Stockholders Equity 28 Comprehensive Income 60

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$69.66M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$45.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$55.97M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$105.00K	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$105.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.44M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$259.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.67M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.10M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$56.33M	USD	Point-in-time
Preferred shares designated (in shares)	`TemporaryEquitySharesAuthorized`	22.89M	shares	Point-in-time
Preferred shares designated (in shares)	`TemporaryEquitySharesAuthorized`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$341.53M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`TemporaryEquitySharesIssued`	22.89M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`TemporaryEquitySharesIssued`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$84.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$125.00K	USD	Point-in-time
Deferred offering costs	`DeferredCosts`	$25.00K	USD	Point-in-time
Deferred offering costs	`DeferredCosts`	$8.00K	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`TemporaryEquitySharesOutstanding`	22.89M	shares	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$238.00K	USD	Point-in-time
Preferred stock, aggregate liquidation preference	`TemporaryEquityLiquidationPreference`	$120.00M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$1.17M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$41.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$47.49M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$347.10M	USD	Point-in-time
Total assets	`Assets`	$56.47M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares designated (in shares)	`CommonStockSharesAuthorized`	43.92M	shares	Point-in-time
Common stock, shares designated (in shares)	`CommonStockSharesAuthorized`	43.92M	shares	Point-in-time
Common stock, shares designated (in shares)	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares designated (in shares)	`CommonStockSharesAuthorized`	44.75M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.67M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$212.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.22M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.09M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$13.35M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.21M	USD	Point-in-time
Accrued milestone	`AccruedMilestoneLiabilitiesCurrent`	$10.00M	USD	Point-in-time
Accrued milestone	`AccruedMilestoneLiabilitiesCurrent`	$10.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$28.02M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.30M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.43M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$17.43M	USD	Point-in-time
Total liabilities	`Liabilities`	$28.19M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred shares (Series A, B and C), $0.000273235 par value; 0 shares and 22,885,492 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively; aggregate liquidation preference of $0 and $120,000 as of September 30, 2018 and December 31, 2017, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Convertible preferred shares (Series A, B and C), $0.000273235 par value; 0 shares and 22,885,492 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively; aggregate liquidation preference of $0 and $120,000 as of September 30, 2018 and December 31, 2017, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$79.90M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$392.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$470.60M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-91.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-26.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-151.65M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$318.91M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$-25.73M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$-2.14M	USD	Point-in-time
Total liabilities, convertible preferred shares and shareholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$56.47M	USD	Point-in-time
Total liabilities, convertible preferred shares and shareholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$347.10M	USD	Point-in-time
Total liabilities, convertible preferred shares and shareholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$47.49M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$17.44M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$50.48M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$20.64M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$26.43M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$14.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$56.36M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$9.04M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.56M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.26M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$13.55M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.24M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.51M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$64.03M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$65.40M	USD	Annual
Total operating expenses	`OperatingExpenses`	$26.16M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$16.25M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$32.69M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$24.00M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-64.03M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-32.69M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-16.25M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-24.00M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-65.40M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-26.16M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$169.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$396.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.62M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.99M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$65.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$529.00K	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-16.08M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-32.29M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-24.54M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.94M	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-61.03M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-64.87M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$36.00K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$-51.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$-131.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$-121.00K	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$-386.00K	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-60.65M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-16.03M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-24.41M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-64.87M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-32.17M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-23.97M	USD	Annual
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-91.61	USD	Annual
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-35.85	USD	Annual
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.62	USD	3 Qtrs
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	1 Quarter
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-19.21	USD	3 Qtrs
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.25	USD	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	48.18M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.94M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	23.17M	shares	3 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.81M	shares	Annual
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.68M	shares	3 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	261,695.00	shares	Annual

Cash Flow Statement 69 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-32.17M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-60.65M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-64.87M	USD	Annual
Net loss	`ProfitLoss`	$-23.97M	USD	Annual
Depreciation expense	`Depreciation`	$20.00K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$8.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$22.00K	USD	Annual
Depreciation expense	`Depreciation`	$12.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$28.00K	USD	Annual
Depreciation expense	`Depreciation`	$32.00K	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$897.00K	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$550.00K	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$368.00K	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$3.12M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-935.00K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-168.00K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-197.00K	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-46.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.03M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.19M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.41M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$219.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.98M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$119.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.01M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.01M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$4.11M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$6.45M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.86M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$323.00K	USD	3 Qtrs
Accrued milestone	`IncreaseDecreaseInAccruedMilestone`	$10.00M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.87M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-50.22M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.84M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-53.37M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.27M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$69.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$65.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-69.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-65.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-268.86M	USD	3 Qtrs
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$76.00K	USD	3 Qtrs
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$10.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$39.87M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$346.44M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$39.87M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$42.51M	USD	Annual
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$24.21M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$12.97M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-10.41M	USD	Annual
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$20.64M	USD	Annual
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.66M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.04M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$35.44M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$56.08M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.87M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$35.44M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.66M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.04M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$56.08M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.87M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$345.00K	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$290.00K	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$115.00K	USD	Annual
Deferred offering costs included in accrued expenses and accounts payable	`DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable`	$25.00K	USD	Annual
Deferred offering costs included in accrued expenses and accounts payable	`DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable`	$11.00K	USD	3 Qtrs
Deferred offering costs included in accrued expenses and accounts payable	`DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable`	$8.00K	USD	Annual

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of the period	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Balance at the beginning of the period	`TemporaryEquityCarryingAmountAttributableToParent`	$79.90M	USD	Point-in-time
Balance at the beginning of the period (in shares)	`TemporaryEquitySharesOutstanding`	22.89M	shares	Point-in-time
Balance at the end of the period	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Balance at the end of the period	`TemporaryEquityCarryingAmountAttributableToParent`	$79.90M	USD	Point-in-time
Balance at the end of the period (in shares)	`TemporaryEquitySharesOutstanding`	22.89M	shares	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$-25.73M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$318.91M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$-2.14M	USD	Point-in-time
Conversion of convertible preferred shares into common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$310.59M	USD	3 Qtrs
Issuance of Class A common shares upon completion of initial public offering, net of underwriting discounts and commissions and offering costs	`StockIssuedDuringPeriodValueNewIssues`	$155.54M	USD	3 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$10.00K	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$76.00K	USD	3 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$897.00K	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.12M	USD	3 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$368.00K	USD	Annual
Unrealized gain (loss) on short term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-55.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-32.17M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-64.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-23.97M	USD	Annual
Net loss	`NetIncomeLoss`	$-24.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-60.65M	USD	3 Qtrs
Balance at the end of the period	`StockholdersEquity`	$318.91M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$-25.73M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$-2.14M	USD	Point-in-time

Comprehensive Income 60 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$17.44M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$50.48M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$20.64M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$26.43M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$14.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$56.36M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$9.04M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.56M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.26M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$13.55M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.24M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.51M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$64.03M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$65.40M	USD	Annual
Total operating expenses	`OperatingExpenses`	$26.16M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$16.25M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$32.69M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$24.00M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-64.03M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-32.69M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-16.25M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-24.00M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-65.40M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-26.16M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$169.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$396.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.62M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.99M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$65.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$529.00K	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-16.08M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-32.29M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-24.54M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.94M	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-61.03M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-64.87M	USD	Annual
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$36.00K	USD	Annual
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-51.00K	USD	1 Quarter
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-131.00K	USD	1 Quarter
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	Annual
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-121.00K	USD	3 Qtrs
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-386.00K	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-60.65M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-16.03M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-24.41M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-64.87M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-32.17M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-23.97M	USD	Annual
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-91.61	USD	Annual
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-35.85	USD	Annual
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.62	USD	3 Qtrs
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	1 Quarter
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-19.21	USD	3 Qtrs
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.25	USD	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	48.18M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.94M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	23.17M	shares	3 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.81M	shares	Annual
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.68M	shares	3 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	261,695.00	shares	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.